Interim / Quarterly Report • Aug 25, 2015
Interim / Quarterly Report
Open in ViewerOpens in native device viewer
| Highlights 2 | |
|---|---|
| Summary of the 2nd Quarter 2015 and H1 2015 3 | |
| Financial Review 5 | |
| Outlook 9 | |
| Risks 10 | |
| Events after the Date of the Statement of Financial Position 10 | |
| Confirmation from the Board of Directors and the CEO 11 | |
| Consolidated Income Statement 12 | |
| Consolidated Statement of Comprehensive Income 13 | |
| Consolidated Statement of Financial Position 14 | |
| Consolidated Cash Flow Statement 16 | |
| Consolidated Statement of Changes in Equity 17 | |
| Notes to the Account 18 | |
| Contacts 29 |
| Q2 | Q2 | YTD | YTD | |
|---|---|---|---|---|
| DKK 1,000 | 2015 | 2014 | 2015 | 2014 |
| INCOME STATEMENT, SEGMENTS AND CASH FLOW | ||||
| Group - Operating revenue | 799,947 | 710,602 | 1,413,144 | 1,341,913 |
| Group - Operational EBIT* | 303,419 | 212,114 | 538,290 | 397,617 |
| Group - Profit for the period | 191,069 | 126,210 | 323,494 | 213,390 |
| Operational EBIT (Farming and VAP)(DKK) | 279,893 | 179,985 | 496,741 | 356,706 |
| Operational EBIT*/kg (Farming and VAP)(DKK) | 19.74 | 16.05 | 20.78 | 17.42 |
| Operational EBIT*/kg (Farming and VAP) (NOK) | 22.62 | 17.66 | 24.07 | 19.35 |
| Farming - Operating revenue | 608,993 | 515,578 | 1,080,291 | 1,033,690 |
| Farming - Operational EBIT* | 248,402 | 159,524 | 443,386 | 345,708 |
| Farming - Operational EBIT margin | 41% | 31% | 41% | 33% |
| Farming - Operational EBIT/kg (DKK) | 17.52 | 14.23 | 18.55 | 16.88 |
| Farming - Operational EBIT/kg (NOK) | 20.07 | 15.65 | 21.49 | 18.75 |
| VAP - Operating revenue | 190,752 | 266,951 | 379,847 | 499,203 |
| VAP - Operational EBIT* | 31,491 | 20,461 | 53,355 | 10,998 |
| VAP - Operational EBIT margin | 17% | 8% | 14% | 2% |
| VAP - Operational EBIT/kg (DKK) | 6.22 | 3.44 | 5.56 | 0.93 |
| VAP - Operational EBIT/kg (NOK) | 7.13 | 3.79 | 6.45 | 1.04 |
| FOF - Operating revenue | 283,521 | 280,117 | 488,449 | 458,169 |
| FOF – EBITDA | 53,004 | 56,951 | 115,568 | 79,115 |
| FOF - EBITDA margin | 18.69% | 20.33% | 23.66% | 17.27% |
| Cash flow from operations | 325,551 | 307,794 | 406,553 | 416,133 |
| DKK/NOK (average) | 87.26 | 90.89 | 86.31 | 90.02 |
| FINANCIAL POSITION | ||||
| Total Assets** | 3,497,700 | 3,462,933 | 3,497,700 | 3,462,933 |
| Equity** | 2,121,263 | 2,063,653 | 2,121,263 | 2,063,653 |
| Equity ratio** | 61% | 60% | 61% | 60% |
| Net interest bearing debt (incl. fin. derivatives)** | 301,900 | 232,711 | 301,900 | 232,711 |
| PROFITABILITY | ||||
| Basic earnings per share (DKK) | 3.91 | 2.60 | 6.67 | 4.40 |
| Diluted earnings per share (DKK) | 3.91 | 2.60 | 6.67 | 4.40 |
| ROE*** | 8.8% | 7.4% | 14.9% | 12.8% |
| ROCE (for the last quarter)**** | 9.3% | 9.0% | 16.5% | 17.0% |
| ROCE (for the last 4 quarters) | 32.3% | 31.9% | 32.3% | 32.8% |
| ROIC (for the last quarter)* | 11.5% | 10.5% | 19.9% | 17.3% |
| ROIC (for the last 4 quarters) | 46.1% | 41.6% | 46.1% | 36.6% |
| VOLUMES | ||||
| Harvested volume (tonnes gutted weight) | 14,182 | 11,212 | 23,908 | 20,481 |
| VAP produced volume (tonnes gutted weight) | 5,064 | 5,941 | 9,589 | 11,772 |
| Sold feed tonnes | 17,657 | 18,827 | 32,057 | 32,783 |
* Aligned for fair value adjustment of biomass, onerous contracts provisions and income from associates
** Comparing figures from end 2014
*** Return on average equity based on profit or loss for the period
**** Return on average invested capital based on operational EBIT
***** Return on average invested capital based on EBITA
(Figures in parenthesis refer to the same period last year)
The Bakkafrost Group delivered a total operating EBIT of DKK 303.4 million in Q2 2015. Harvested volumes were record high at 14.2 thousand tonnes gutted weight in Q2 2015. The combined farming and VAP segments made an operational EBIT of DKK 279.9 million in Q2 2015. The Farming segment made an operational EBIT of DKK 248.4 million. The global salmon spot prices continued to decrease in Q2 2015. The decrease in spot prices had a positive effect on Bakkafrost's VAP segment, which had stable market conditions and made an operational EBIT of DKK 31.5 million in Q2 2015. The EBITDA for the FOF segment was DKK 53.0 million in Q2 2015.
The Group made a profit for the quarter of DKK 191.1 million (DKK 126.2 million). For H1 2015, the profit was DKK 323.5 million (DKK 213.4 million).
The total volumes harvested in Q2 2015 were 14,182 tonnes gutted weight (11,212 tgw), which is record high harvest in a quarter for Bakkafrost. Total harvested volumes in H1 2015 were 23,908 tonnes gutted weight (20,481 tgw). The guidance for volumes for 2015 is unchanged.
Bakkafrost transferred 1.4 million smolts in Q2 2015 (1.9 million), which is in line with the company's plans. Transferred smolts in H1 2015 were 3.6 million smolts (4.9 million).
In accordance with the Group's dividend policy and the resolution of the Annual General Meeting 2015, Bakkafrost paid out DKK 6.00 (NOK 6.78) per share in April 2015 as dividend for 2014. This corresponds to DKK 293.1 million (NOK 331.1 million).
The combined farming and VAP segments made an operational EBIT of DKK 279.9 million (DKK 180.0 million) in Q2 2015. For H1 2015, the combined farming and VAP segment made an operational EBIT of DKK 496.7 million (DKK 356.7 million).
The farming segment made an operational EBIT of DKK 248.4 million (DKK 159.5 million) in Q2 2015. The harvested volumes are higher, while the average spot price is lower in Q2 2015, compared with Q2 2014. For H1 2015, the operational EBIT was DKK 443.4 million (DKK 345.7 million).
The VAP segment made an operational EBIT of DKK 31.5 million (DKK 20.5 million) for Q2 2015. There is normally a time lag between the changes in the spot prices and the changes in the contract prices. The contract prices have increased significantly from the level in Q2 2014. Therefore, the VAP result for Q2 2015 has improved, compared to last year. For H1 2015, the operational EBIT was DKK 53.4 (DKK 11.0 million).
The FOF segment (fishmeal, oil and feed) made an operational EBITDA of DKK 53.0 million (DKK 57.0 million) in Q2 2015. The record high EBITDA margin of 30.5% in Q1 2015 decreased to 18.7% in Q2 2015, as expected. The high margin in Q1 2015 was primarily due to low purchase prices during the autumn last year, and this effect diminished in Q2 2015. The operational EBITDA was 115.6 million in H1 2015 (DKK 79.1 million), corresponding to an EBITDA margin of 23.7% for H1 2015.
In Q2 2015, Havsbrún sourced 86,012 tonnes of raw material (107,372 tonnes) and in H1 2015, Havsbrún sourced 161,015 tonnes of raw material (151,531 tonnes).
The Bakkafrost Group's net interest bearing debt amounted to DKK 301.9 million at the end of Q2 2015 (DKK 232.7 million at year-end 2014) including deposits and losses on financial derivatives relating to the interest bearing debt. Bakkafrost had undrawn credit facilities of approximately DKK 720.7 million, of which DKK 17.8 million were restricted at the end of Q2 2015.
Bakkafrost's equity ratio at 30 June 2015 is 61%, compared with 60% at the end of 2014.
| Q2 | Q2 | YTD | YTD | |
|---|---|---|---|---|
| Operational EBIT/kg | 2015 | 2014 | 2015 | 2014 |
| Farming EBIT/kg (DKK) | 17.52 | 14.23 | 18.55 | 16.88 |
| Farming EBIT/kg (NOK) | 20.07 | 15.65 | 21.49 | 18.75 |
| VAP EBIT/kg (DKK) | 6.22 | 3.44 | 5.56 | 0.93 |
| VAP EBIT/kg (NOK) | 7.13 | 3.79 | 6.45 | 1.04 |
| Bakkafrost Group | |||||
|---|---|---|---|---|---|
| 1,000 pieces | 2011 | 2012 | 2013 | 2014 | 2015E |
| Farming North | 5,000 | 6,500 | 7,200 | 3,000 | 6,600 |
| Farming West | 2,600 | 4,200 | 2,300 | 7,400 | 3,800 |
| Viking | 1,000 | 0 | 0 | 0 | 0 |
| Total | 8,600 | 10,700 | 9,500 | 10,400 | 10,400 |
(Figures in parenthesis refer to the same period last year)
The operating revenues amounted to DKK 799.9 million in Q2 2015 (DKK 710.6 million) and for H1 2015, the operating revenues amounted to DKK 1,413.1 million (DKK 1,341.9 million). The increase in revenue is due to higher volumes in the Farming segment and higher prices in the FOF segment.
Operational EBIT in Q2 2015 was DKK 303.4 million (DKK 212.1 million). Improved margins in the Farming and VAP segments in Q2 2015, compared with Q2 2014, resulted in an improved overall operational EBIT margin. The margin in the FOF segment was slightly lower in Q2 2015, compared with Q2 2014. For H1 2015, the operational EBIT was DKK 538.3 million (DKK 397.6 million).
A fair value adjustment of the Group's biological assets has been recognised in Q2 2015 amounting to DKK -38.0 million (DKK -9.8 million). The negative adjustment is due to lower salmon spot prices at the end of Q2 2015, compared with the beginning of the quarter. For H1 2015, the fair value adjustment amounted to DKK -93.0 million (DKK -123.6 million).
No changes were made to the provisions of onerous contracts in Q2 2015, similar to Q2 2014, as no contracts were onerous at the beginning and at the end of the quarter.
For H1 2015, no changes were made to the provisions of onerous contracts (DKK 70.9 million).
In Q2 2015, there was a loss from associated companies amounting to DKK -10.8 million (DKK 10.1 million). For H1 2015, the loss from associated companies amounted to DKK -13.7 million (DKK 3.0 million).
Net interests in Q2 2015 were DKK -17.4 million (DKK -0.5 million), whereof a positive unrealised exchange rate adjustment of DKK 4.8 million relating to the bond loan of NOK 500 million is posted in Q2 2015. For H1 2015, net interests were DKK -28.3 million (DKK -18.0 million).
Net taxes in Q2 2015 amounted to DKK -46.1 million (DKK -85.7 million). For H1 2015, net taxes amounted to DKK -79.9 million (DKK -116.5 million).
The result for Q2 2015 was DKK 191.1 million (DKK 126.2 million) and for H1 2015, the result was DKK 323.5 million (DKK 213.4).
| Q2 | Q2 | YTD | YTD | |
|---|---|---|---|---|
| Harvested volumes (tgw) | 2015 | 2014 | 2015 | 2014 |
| Farming North | 11,681 | 7,874 | 18,866 | 8,195 |
| Farming West | 2,501 | 3,338 | 5,042 | 12,286 |
| Total harvested volumes (tgw) | 14,182 | 11,212 | 23,908 | 20,481 |
(Figures in parenthesis refer to the same period last year)
Bakkafrost has three operating segments: Farming, VAP (value added products) and FOF (fishmeal, fish oil and fish feed). The fresh/frozen salmon is sold in the spot market, while VAP products are sold on long-term contracts.
| Distribution of harvested | Q2 | Q2 | YTD | YTD |
|---|---|---|---|---|
| volumes (tgw) | 2015 | 2014 | 2015 | 2014 |
| Harvested volume used in VAP production | 30% | 53% | 36% | 53% |
| Harvested volume sold fresh/frozen | 70% | 47% | 64% | 47% |
| Harvested and purchased volumes (tgw) | 100% | 100% | 100% | 100% |
Of the total harvested volumes in Q2 2015, 30% (53%) went for the production of VAP products, and 70% (47%) were sold as whole gutted salmon. In H1 2015, 36% (53%) went for the production of VAP products, and 64% (47%) were sold as whole gutted salmon. In addition to the harvested volumes that went for the VAP production, Bakkafrost also sourced some salmon from a third party.
In Q2 2015, the operating revenue for Bakkafrost's farming segment was DKK 609.0 million (DKK 515.6 million). For H1 2015, the operating revenue for the farming segment was DKK 1,080.3 million (DKK 1,033.7 million).
Operational EBIT, which is EBIT before fair value adjustments on biological assets, provisions for onerous contracts and income from associates, amounted to DKK 248.4 million in Q2 2015 (DKK 159.5 million). For H1 2015, operational EBIT was DKK 443.4 million (DKK 345.7 million).
Operational EBIT/kg for the farming segment was DKK 17.52 (NOK 20.07) in Q2 2015, compared with DKK 14.23 (NOK 15.65) in Q2 2014. In general, the average salmon NOS prices have been lower in Q2 2015, than during the same period in 2014. Prices achieved by Bakkafrost, however, have been higher in Q2 2015, than in Q2 2014. Operational EBIT/kg for H1 2015 was DKK 18.55 (NOK 21.49), compared with DKK 16.88 (NOK 18.75) for H1 2014.
The operating revenue for the VAP segment amounted to DKK 190.8 million (DKK 267.0 million) in Q2 2015. The decrease in revenue is because of lower volumes produced and sold in Q2 2015, compared with Q2 2014. The contract prices were higher in Q2 2015, compared with Q2 2014. For H1 2015, operating revenue was DKK 379.8 million (DKK 499.2 million).
Operational EBIT amounted to DKK 31.5 million (DKK 20.5 million) in Q2 2015, corresponding to an operational EBIT of DKK 6.22 (NOK 7.13) per kg gutted weight in Q2 2015, compared with DKK 3.44 (NOK 3.79) per kg gutted weight in Q2 2014. The increase in the operational EBIT margins is due to higher contract prices and lower salmon spot prices. The VAP segment purchases its raw material (fresh salmon) at spot prices each week. For H1 2015, operational EBIT amounted to DKK 53.4 million (DKK 11.0 million), corresponding to an operational EBIT of DKK 5.56 (NOK 6.45) per kg gutted weight in H1 2015, compared with an operational EBIT of DKK 0.93 (NOK 1.04) per kg gutted weight in H1 2014.
The operating revenue for the FOF segment amounted to DKK 283.5 million (DKK 280.1 million) in Q2 2015, of which DKK 158.7 million (DKK 146.7 million) represents sales to Bakkafrost's farming segment, corresponding to 56.0% (52.4%). For H1 2015, the revenue amounted to DKK 488.4 million (DKK 458.2), of which DKK 280.7 million (DKK 239.7 million) represents sales to Bakkafrost's farming segment and corresponds to 57.4% (52.3%).
Operational EBITDA was DKK 53.0 million (DKK 57.0 million) in Q2 2015, and the operational EBITDA margin was 18.7% (20.3%). Havsbrún sources raw pelagic fish for the fishmeal and fish oil production, which are part of the recipe for the production of salmon feed. The raw fish, which was purchased in Q3 and Q4 in 2014 at favourable prices, was mainly used in the salmon feed pro-
duction in Q1 2015. This had a positive effect on the margins in Q1 2015. This effect diminished in Q2 2015. For H1 2015, the operational EBITDA was DKK 115.6 million (DKK 79.1 million), corresponding to an EBITDA margin of 23.7% (17.3%).
Sales of feed amounted to 17,657 tonnes (18,827 tonnes) in Q2 2015, of which the farming segment internally used 15,551 tonnes (14,784 tonnes) or 88.1% (78.5%). In H1 2015, the feed sale was 32,057 tonnes (32.783 tonnes). The internal sale to the farming segment was 27.961 tonnes (25.382 tonnes) in H1 2015, corresponding to 87.2% (77.4%).
In Q2 2015, Havsbrún received 86,012 tonnes (107,372 tonnes) of raw material for the production of fishmeal and fish oil. In general, the raw material
(Figures in parenthesis refer to end last year)
The Group's total assets as at end Q2 2015 amounted to DKK 3,497.7 million, compared with DKK 3,462.9 million at the end of 2014.
The Group's intangible assets are unchanged, compared to the beginning of the year, and amounted to DKK 294.7 million. Intangible assets comprise primarily the fair value of acquired farming licences. No licences in the North region are recorded with a value in the Bakkafrost accounts.
Property, plant and equipment amounted to DKK 1,168.2 million at the end of Q2 2015, compared with DKK 1,041.2 million at the end of 2014. In Q2 2015, Bakkafrost made investments in PP&E amounting to DKK 73.0 million and in H1 2015, investments were made for DKK 179.5 million.
Non-current financial assets amounted to DKK 112.8 million at the end of Q2 2015, compared with DKK 125.4 million at the end of 2014.
Bakkafrost has no long-term receivables at the end of Q2 2015, coming down from DKK 1.3 million at end 2014.
The Group's carrying amount (fair value) of biological assets amounted to DKK 902.5 million at the end of Q2 2015, compared with DKK 1,014.0 million at the end of 2014. Included in the carrying amount of the biological assets is a fair value adjustment amounting to DKK 191.9 million, compared with DKK 284.9 million at the end of 2014. The decrease is due to lower salmon prices at the intake depends on the available quotas and catch of pelagic fish species in the North Atlantic. In H1 2015, Havsbrún received 161,015 tonnes (151,531 tonnes) of raw material.
The production of fishmeal in Q2 2015 was 17,600 tonnes (21,925 tonnes). In H1 2015, Havsbrún's fishmeal production was 32,888 tonnes (31,939 tonnes).
The production of fish oil in Q2 2015 was 489 tonnes (391 tonnes). In H1 2015, Havsbrún produced 2,637 tonnes (1,659 tonnes) of fish oil. The production of fishmeal and fish oil varies, depending on the species of fish sourced for production and timing of catch. The main raw material intake of Havsbrún in H1 2015 is blue whiting, similar to H1 2014. The content of fish oil in blue whiting is normally lower in Q2, than in Q1.
end of Q2 2015, compared to end 2014, but also due to seasonal lower biomass at sea.
The Group's total inventories amounted to DKK 418.9 million as at end Q2 2015, compared with DKK 267.0 million at year-end 2014. The inventory primarily represents Havsbrún's inventory of fishmeal, fish oil and fish feed in addition to feed at the feed stations, finished products, packing materials and other raw materials.
The Group's total receivables amounted to DKK 206.9 million as at end Q2 2015, compared with DKK 172.4 million at the end of 2014.
The Group's equity at the end of Q2 2015 is DKK 2,121.3 million, compared with DKK 2.063,7 million at the end of 2014. The change in equity consists primarily of the positive result for the period, a fair value adjustment to a currency-/interest rate swap related to the bond financing and the gross dividend of DKK 293.1 million paid out in April 2015.
The Group's total non-current liabilities amounted to DKK 1,136.0 million at the end of Q2 2015, compared with DKK 1,036.3 million at the end of 2014.
Deferred and other taxes at the end of Q2 2015 amounted to DKK 495.2 million, compared with DKK 414.0 million at the end of 2014.
Long-term debt was DKK 549.0 million at the end of Q2 2015, compared with DKK 505.4 million at the end of 2014. Derivatives amounted to DKK
91.8 million at the end of Q2 2015, compared with DKK 116.9 million at the end of 2014.
Bakkafrost's interests bearing debt consists of one bank loan and a bond loan. Bakkafrost decided to prepay the instalment loan of DKK 175 million in Q2 2015. The instalment loan was payable with DKK 25 million each quarter until year end 2016. Bakkafrost's remaining bank loan is an overdraft facility, payable in 2016 with the full amount of DKK 553 million. The bond loan of NOK 500 million has a five-year maturity and is payable 14 February 2018. The interest rate of the bonds is NIBOR 3m + 4.15%. Following the issuance of the bonds, Bakkafrost has entered into a currency/-interest rate swap, hedging the exchange rate, and has switched the interest rate from NIBOR 3m to CIBOR 3m. Bakkafrost has entered the swap due
(Figures in parenthesis refer to the same period last year)
The cash flow from operations in Q2 2015 was DKK 325.6 million (DKK 307.8 million). The working capital is nearly unchanged in Q2 2015. For H1 2015, the cash flow from operations was DKK 406.6 million (DKK 416.1 million).
The cash flow from investment activities in Q2 2015 amounted to DKK -71.7 million (DKK -71.5 million). The amount relates mainly to investments in fixed assets. For H1 2015, the cash flow from investments amounted to DKK -178.2 million (DKK -105.7 million).
Cash flow from financing activities totalled DKK -372.8 million in Q2 2015 (DKK -217.0 million). The interest bearing debt decreased by DKK 52.1 million and had a negative effect on cash flow from to its exposure to DKK, as a large part of the income and costs are in DKK and EUR.
At the end of Q2 2015, the Group's total current liabilities are DKK 240.4 million, compared with DKK 362.9 million at the end of 2014. The main change in total current liabilities in Q2 is that Bakkafrost has no short-term interest bearing debt at the end of Q2 2015, because of Bakkafrost's prepayment of the bank instalment loan debt as described above. Accounts payable amount to DKK 240.4 million, compared with DKK 262.9 million at the end of 2014.
Bakkafrost's equity ratio is 61% at the end of Q2 2015, compared with 60% at the end of 2014.
financing. Likewise, financing of an associated company contributed negatively with DKK 23.1 million and the net payment of dividend of DKK 291.0 million in April 2015. For H1 2015, cash flow from financing amounted to DKK -337.6 million (DKK -229.7 million).
Net change in cash flow in Q2 2015 amounted to DKK -119.0 million (DKK 19.3 million) and for H1 2015, DKK -109.3 million (DKK 80.7 million).
At the end of Q2 2015, Bakkafrost had unused credit facilities of approximately DKK 720.7 million of which DKK 17.8 million are restricted.
The global demand growth in the salmon market has increased during the last years due to high growth rate in emerging markets and a stable growth in other markets. Expected global supply growth in 2015 is around 4-5% and 2-3% in 2016. Production capacity is close to full utilization and further expansion relates to high investments.
The Russian ban on Norwegian salmon implemented in August 2014 gave temporary challenges to move volumes between different markets. Going forward we expect the global market to adapt better to the new market balance.
The market place is one of Bakkafrost's most significant risk areas. Bakkafrost has a geographical and a market price approach. These approaches reduce the exposure to the market risk. To diversify the geographical market risk, Bakkafrost sells its products to some of the largest salmon markets in the world, the US, the Far East, Europe and Russia.
The outlook for the farming segment is good. Biology and veterinary situation is the most important risk area for Bakkafrost. The company is focusing on this risk with new investments and procedures to minimise the risk. The biological situation is good, and the price outlook in the spot market continues to be positive.
Bakkafrost's expected harvest is unchanged at 49,000-51,000 tonnes gutted weight in 2015. Faroe Farming, a company in which Bakkafrost holds 49%, expects to harvest around 4,500 tonnes in 2015.
The number of smolts released is one key element of predicting the future production for the Group. Bakkafrost forecasts a release of 10.4 million smolts in 2015, compared with the 9.5 million smolts released in 2013, as the same sites are available for smolt release.
The estimates for harvesting volumes and smolt releases are as always dependent on the biological situation. Bakkafrost's new wellboat, Hans á Bakka, was delivered in July and started operating in August 2015. Hans á Bakka has fresh water treatment systems installed, which can be used in treatment against sea lice and other diseases.
The outlook for sales of value added products is good. Bakkafrost has signed contracts covering around 75% of the VAP capacity for the rest of 2015. This corresponds to around 28% of the expected harvested volumes for the rest of 2015. The remaining 25% of the VAP capacity is expected to be committed during the year. The VAP contracts are at fixed prices, based on the salmon forward prices at the time they are agreed and the expectations for the salmon spot price for the contract period.
The contracts last for 6 to 12 months. The longterm strategy is to sell around 40-50% of the harvested volumes of salmon as VAP products on fixed price contracts. Selling the products at fixed prices reduces the financial risk with fluctuating salmon prices. The market price for contracted VAP products follows a more stable pattern with trends instead of short-term fluctuations as in the spot market.
The outlook for the production of fishmeal and fish oil has improved as the available raw material for the production has increased. The quotas for catching blue whiting in the North Atlantic have increased.
With increased quotas, Bakkafrost is optimistic that the raw materials needed for our production of high quality salmon feed will be available.
Depending on supply, demand and the price level, however, the sourcing of raw material for the production of fishmeal and fish oil may be uncertain. An alternative to Havsbrún's production of fishmeal and fish oil is purchasing these raw materials from other producers. Fishmeal and fish oil are the most important raw materials in the production of a high quality fish feed for the Bakkafrost salmon.
The major market for Havsbrún´s fish feed is the local Faroese market, including Bakkafrost's internal use of fish feed.
Havsbrún's sales of fish feed in 2015 is expected to be at 73,000 – 77,000 tonnes. This is a reduction from the previous outlook at 83,000 – 87,000 tonnes, as the sale of fish feed to external customers has been reduced. The expected feed purchase from Bakkafrost's farming segment in 2015 is unchanged.
Bakkafrost has announced an investment plan for the period until 2017, latest updated in August 2014. The purpose of the investment plan is to continue to have one of the most costs efficient value chains in the farming industry, carry out organic growth, increase flexibility and reduce the biological risk to meet the future consumers' trends and to be more end-customer orientated.
The total investments for the period 2014-2017 were announced to be DKK 1,370 million including maintenance CAPEX. The future investments over the next three years will be DKK 1,120 million. Included in the investment plan is a new harvest/- VAP factory estimated to DKK 450 million, resulting in operational savings of DKK 70-90 million per year from 2017. The plant will be up running in 2016.
Bakkafrost plans to increase the smolt capacity, making Bakkafrost self-supplied with smolts at a size of 200-300g each before end 2017. The benefits are shorter production time at sea as well as reduced biological risk. As part of this plan, the expansion of one existing hatchery started early 2015. The expansion will fourfold the capacity of this hatchery, which will be finished within one year.
Free cash flow from operations, existing financing facilities and partly new financing if advantageous will finance the investments. In addition, Bakkafrost has the possibility to postpone investments in case of adverse events. The dividend policy will be unchanged.
Improved market balances in the world market for salmon products and costs effective production will likely improve the financial flexibility going forward. A high equity ratio together with the Group's bank financing and the issuance of bonds makes Bakkafrost's financial situation strong. This enables Bakkafrost to carry out its investment plans to further focus on strengthening the Group, M&A's, organic growth opportunities and fulfil its dividend policy in the future.
Bakkafrost has not identified any additional risk exposure beyond the risks described in the 2014 Annual Report.
The 2014 Annual Report is available on request from Bakkafrost and on Bakkafrost's website, www.bakkafrost.com.
Bakkafrost is, as explained in the 2014 Annual Report, exposed to the salmon price. A limited increase in supply is expected in 2015 and therefore a balanced salmon market.
References are made to the Outlook section of this report for other comments to Bakkafrost's risk exposure and to Note 3.
From the date of the statement of financial position until today, no events have occurred which materially influence the information provided by this report.
We confirm, to the best of our knowledge, that the interim financial report for the first half of 2015 has been prepared in accordance with IFRS, as adopted by EU, and gives a true and fair view of the Group's consolidated assets, liabilities, financial position and results for the period. Furthermore, we confirm that the interim management report includes a fair review of the information required under the Norwegian Securities Trading Act § 5–6, fourth paragraph.
Glyvrar, August 25th 2015
The Board of Directors and the CEO of P/F Bakkafrost
Rúni M. Hansen Johannes Jensen Øystein Sandvik Chairman of the Board Deputy Chairman of the Board Board Member
Virgar Dahl Annika Frederiksberg Tor Magne Lønnum Board Member Board Member Board Member
Regin Jacobsen CEO
For the period ended 30 June 2015
| Q2 | Q2 | YTD | YTD | |
|---|---|---|---|---|
| DKK 1,000 | 2015 | 2014 | 2015 | 2014 |
| Operating revenue | 799,947 | 710,602 | 1,413,144 | 1,341,913 |
| Purchase of goods | -263,099 | -252,610 | -567,183 | -483,503 |
| Change in inventory and biological assets (at cost) | 28,169 | 13,128 | 196,088 | 28,351 |
| Salary and personnel expenses | -76,606 | -71,970 | -140,681 | -133,648 |
| Other operating expenses | -158,667 | -163,685 | -310,501 | -309,571 |
| Depreciation | -26,325 | -23,351 | -52,577 | -45,925 |
| Operational EBIT * | 303,419 | 212,114 | 538,290 | 397,617 |
| Fair value adjustments on biological assets | -38,042 | -9,838 | -92,978 | -123,618 |
| Onerous contracts | 0 | 22 | 0 | 70,908 |
| Income from associates | -10,796 | 10,075 | -13,663 | 2,978 |
| Earnings before interest and taxes (EBIT) | 254,581 | 212,373 | 431,649 | 347,885 |
| Net interest revenue | 479 | 690 | 1,413 | 1,289 |
| Net interest expenses | -6,187 | -7,971 | -13,926 | -16,508 |
| Net currency effects | -8,630 | 8,425 | -11,201 | -26 |
| Other financial expenses | -3,040 | -1,597 | -4,576 | -2,720 |
| Earnings before taxes (EBT) | 237,203 | 211,920 | 403,359 | 329,920 |
| Taxes | -46,134 | -85,710 | -79,865 | -116,530 |
| Profit or loss for the period | 191,069 | 126,210 | 323,494 | 213,390 |
| Profit or loss for the year attributable to | ||||
| Non-controlling interests | 0 | 0 | 0 | 0 |
| Owners of P/F Bakkafrost | 191,069 | 126,210 | 323,494 | 213,390 |
| Earnings per share (DKK) | 3.91 | 2.60 | 6.67 | 4.04 |
| Diluted earnings per share (DKK) | 3.91 | 2.60 | 6.67 | 4.04 |
*EBIT before fair value on biomass, onerous contratcts and income from associates
For the period ended 30 June 2015
| Q2 | Q2 | YTD | YTD | |
|---|---|---|---|---|
| DKK 1,000 | 2015 | 2014 | 2015 | 2014 |
| Profit for the period | 191,069 | 126,210 | 323,494 | 213,390 |
| Fair value adjustment on financial derivatives | -683 | -11,247 | 24,339 | -893 |
| Income tax effect | 104 | 1,715 | -3,713 | 136 |
| Reserve to share-based payment | 276 | 0 | 462 | 0 |
| Currency translation differences | 2 | 312 | -128 | -81 |
| Net other comprehensive income to be reclassified to profit or loss in subsequent periods |
-301 | -9,220 | 20,960 | -838 |
| Proceeds/Acquisition of treasury shares | 4,050 | 2,693 | 4,141 | 2,693 |
| Net other comprehensive income not to be reclassified to profit or loss in subsequent periods |
4,050 | 2,693 | 4,141 | 2,693 |
| Other comprehensive income | 3,749 | -6,527 | 25,101 | 1,855 |
| Total other comprehensive income for the period | 194,818 | 119,683 | 348,595 | 215,245 |
| Comprehensive income for the period attributable to | ||||
| Non- controlling interests | 0 | 0 | 0 | 0 |
| Owners of P/F Bakkafrost | 194,818 | 119,683 | 348,595 | 215,245 |
As at 30 June 2015
| 30 June | 30 June | 31 Dec | |
|---|---|---|---|
| DKK 1,000 | 2015 | 2014 | 2014 |
| ASSETS | |||
| Non-current assets | |||
| Intangible assets | 294,675 | 294,675 | 294,675 |
| Property, plant and equipment | 1,168,209 | 949,481 | 1,041,248 |
| Financial assets | 112,842 | 131,693 | 125,419 |
| Long term receivables | 0 | 15,035 | 1,291 |
| Total non-current assets | 1,575,726 | 1,390,884 | 1,462,633 |
| Current assets | |||
| Biological assets (biomass) | 902,525 | 812,782 | 1,013,959 |
| Inventory | 418,860 | 284,056 | 266,960 |
| Total inventory | 1,321,385 | 1,096,838 | 1,280,919 |
| Accounts receivable | 206,881 | 311,474 | 172,360 |
| Other receivables | 97,865 | 78,276 | 141,912 |
| Total receivables | 304,746 | 389,750 | 314,272 |
| Cash and cash equivalents | 295,843 | 262,807 | 405,109 |
| Total current assets | 1,921,974 | 1,749,395 | 2,000,300 |
| TOTAL ASSETS | 3,497,700 | 3,140,279 | 3,462,933 |
As at 30 June 2015
| 30 June | 30 June | 31 Dec | |
|---|---|---|---|
| DKK 1,000 | 2015 | 2014 | 2014 |
| EQUITY AND LIABILITIES | |||
| Equity | |||
| Share capital | 48,858 | 48,858 | 48,858 |
| Other equity | 2,072,405 | 1,613,879 | 2,014,795 |
| Total equity | 2,121,263 | 1,662,737 | 2,063,653 |
| Non-current liabilities | |||
| Deferred and other taxes | 495,184 | 417,277 | 414,014 |
| Long-term interest bearing debts | 549,048 | 671,376 | 505,393 |
| Financial derivatives | 91,775 | 72,969 | 116,928 |
| Total non-current liabilities | 1,136,007 | 1,161,622 | 1,036,335 |
| Current liabilities | |||
| Short-term interest bearing debt | 0 | 100,000 | 100,000 |
| Accounts payable and other debt | 240,430 | 215,920 | 262,945 |
| Total current liabilities | 240,430 | 315,920 | 362,945 |
| Total liabilities | 1,376,437 | 1,477,542 | 1,399,280 |
| TOTAL EQUITY AND LIABILITIES | 3,497,700 | 3,140,279 | 3,462,933 |
For the period ended 30 June 2015
| Q2 | Q2 | YTD | YTD | |
|---|---|---|---|---|
| DKK 1,000 | 2015 | 2014 | 2015 | 2014 |
| Earnings before interest and taxes (EBIT) | 254,581 | 212,373 | 431,649 | 347,885 |
| Adjustments for write-downs and depreciation | 26,325 | 23,351 | 52,577 | 45,925 |
| Adjustments for value adjustments on biomass | 38,042 | 9,838 | 92,978 | 123,618 |
| Adjustments for income from associates | 10,796 | -10,075 | 13,663 | -2,978 |
| Adjustments for currency effects | -6,190 | 8,425 | -8,761 | -26 |
| Taxes paid | -3,953 | 0 | -3,953 | 0 |
| Provision for onerous contracts | 0 | -22 | 0 | -70,908 |
| Change in inventory | 22,144 | -13,128 | -133,444 | -19,071 |
| Change in receivables | -9,498 | 50,422 | -15,870 | 64,736 |
| Change in current debts | -6,696 | 26,610 | -22,286 | -73,048 |
| Cash flow from operations | 325,551 | 307,794 | 406,553 | 416,133 |
| Cash flow from investments | ||||
| Payments made for purchase of fixed assets | -73,041 | -61,030 | -179,538 | -78,710 |
| Sale/Purchase of shares | 0 | 3,140 | 0 | -13,409 |
| Change in long-term receivables | 1,314 | -13,563 | 1,314 | -13,563 |
| Cash flow from investments | -71,727 | -71,453 | -178,224 | -105,682 |
| Cash flow from financing | ||||
| Change of interest bearing debt (short and long) | -52,083 | 51,943 | -56,345 | -14,139 |
| Financial income | 479 | 690 | 1,413 | 1,289 |
| Financial expenses | -9,227 | -9,568 | -18,502 | -19,228 |
| Acquisition of treasury shares | 2,049 | 3,437 | 2,742 | 3,437 |
| Financing of associate | -23,065 | -45,378 | 24,081 | 17,080 |
| Dividend paid | -290,985 | -218,160 | -290,985 | -218,160 |
| Cash flow from financing | -372,832 | -217,036 | -337,596 | -229,721 |
| Net change in cash and cash equivalents in period | -119,008 | 19,305 | -109,267 | 80,730 |
| Cash and cash equivalents – opening balance | 414,851 | 243,502 | 405,110 | 182,077 |
| Cash and cash equivalents – closing balance total | 295,843 | 262,807 | 295,843 | 262,807 |
As at 30 June 2015
| Biomass | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Share | Share- | Currency | Fair value | |||||||
| Share | Premium | Treasury | based | translation | Proposed | adjust- | Retained | Total | ||
| DKK 1,000 | Capital | Reserve | Shares | Payment | differences | Derivatives | Dividend | ments | Earnings | Equity |
| Equity 01.01.2015 | 48,858 | 306,537 | -25,557 | 161 | 1,458 | -95,882 | 293,148 | 284,855 | 1,250,075 | 2,063,653 |
| Consolidated profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 92,978 | 230,516 | 323,494 |
| Other comprehensive income: | ||||||||||
| Fair value adjustment on financial derivatives | 0 | 0 | 0 | 0 | 0 | 24,339 | 0 | 0 | 0 | 24,339 |
| Income tax effect | 0 | 0 | 0 | 0 | 0 | -3,713 | 0 | 0 | 0 | -3,713 |
| Share-based payment | 0 | 0 | 0 | 462 | 0 | 0 | 0 | 0 | 0 | 462 |
| Currency translation differences | 0 | 0 | 0 | 0 | -128 | 0 | 0 | 0 | 0 | -128 |
| Total other comprehensive income | 0 | 0 | 0 | 462 | -128 | 20,626 | 0 | 0 | 0 | 20,960 |
| Total comprehensive income | 0 | 0 | 0 | 462 | -128 | 20,626 | 0 | 92,978 | 230,516 | 344,454 |
| Transaction with owners: | ||||||||||
| Treasury shares | 0 | 0 | 4,141 | 0 | 0 | 0 | 0 | 0 | 0 | 4,141 |
| Paid-out dividend | 0 | 0 | 0 | 0 | 0 | 0 | -293,148 | 0 | 2,163 | -290,985 |
| Total transaction with owners | 0 | 0 | 4,141 | 0 | 0 | 0 | -293,148 | 0 | 2,163 | -286,844 |
| Total changes in equity | 0 | 0 | 4,141 | 462 | -128 | 20,626 | -293,148 | 92,978 | 232,679 | 57,610 |
| Total equity 30.06.2015 | 48,858 | 306,537 | -21,416 | 623 | 1,330 | -75,256 | 0 | 377,833 | 1,482,754 | 2,121,263 |
| Equity 01.01.2014 | 48,858 | 306,537 | -28,949 | 0 | 1,109 | -61,409 | 219,862 | 296,402 | 882,867 | 1,665,277 |
| Consolidated profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 123,618 | 89,772 | 213,390 |
| Other comprehensive income: | ||||||||||
| Fair value adjustment on financial derivatives | 0 | 0 | 0 | 0 | 0 | -892 | 0 | 0 | 0 | -892 |
| Income tax effect | 0 | 0 | 0 | 0 | 0 | 136 | 0 | 0 | 0 | 136 |
| Currency translation differences | 0 | 0 | 0 | 0 | 293 | 0 | 0 | 0 | 0 | 293 |
| Total other comprehensive income | 0 | 0 | 0 | 0 | 293 | -756 | 0 | 0 | 0 | -463 |
| Total comprehensive income | 0 | 0 | 0 | 0 | 293 | -756 | 0 | 123,618 | 89,772 | 212,927 |
| Transaction with owners: | ||||||||||
| Treasury shares | 0 | 0 | 0 | 2,693 | 0 | 0 | 0 | 0 | 0 | 2,693 |
| Paid-out dividend | 0 | 0 | 0 | 0 | 0 | 0 | -219,862 | 0 | 1,702 | -218,160 |
| Total transaction with owners | 0 | 0 | 0 | 2,693 | 0 | 0 | -219,862 | 0 | 1,702 | -215,467 |
| Total changes in equity | 0 | 0 | 0 | 2,693 | 293 | -756 | -219,862 | 123,618 | 91,474 | -2,540 |
| Total equity 30.06.2014 | 48,858 | 306,537 | -28,949 | 2,693 | 1,402 | -62,165 | 0 | 420,020 | 974,341 | 1,662,737 |
Condensed Consolidated Interim Report for Q2 2015 and H1 2015 Issued August 25th 2015
P/F Bakkafrost is a limited company incorporated and domiciled in the Faroe Islands.
The Group's Annual Report as at 31st December 2014 is available upon request from the company's
This Condensed Consolidated Interim Report has been prepared in accordance with International Financial Reporting Standards (IFRS) IAS 34 Interim Financial Reporting as adopted by the EU. It does not include all of the information required for the full Annual and Consolidated Report and Accounts
The accounting policies applied by the Group in this Condensed Consolidated Interim Report are the same as those applied in the Annual Report as at and for the year ended 31st December 2014.
The preparation of financial statements in accordance with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting principles and recognised amounts of assets, liabilities, income and expenses. The most significant estimates relate to the valuation of biological assets and some financial instruments, which are measured at fair value. Estimates and underlying assumptions are reviewed on an on-going basis and are based on the management's best assessment at the time of reporting. All changes in estimates are reflected in the financial statements as they occur.
registered office at Bakkavegur 9, FO-625 Glyvrar, Faroe Islands, or at www.bakkafrost.com.
This Condensed Consolidated Interim Report is presented in DKK.
and should be read in conjunction with the Annual and Consolidated Report and Accounts for the Group as at 31st December 2014.
This interim report has not been subject to any external audit.
The company has, nevertheless, chosen to reproduce the note on intangible assets from the Annual Report 2014. The information in the note is enlarged.
The accounting estimates are described in Note 3 to the financial statements in the Annual Report 2014.
For other risk exposures, reference is made to the Management Statement in the Annual Report for 2014, where Bakkafrost's operational and financial risks are described, as well as to Note 22 (Financial risk management) in the same report.
The risks and uncertainties described therein are expected to remain.
| 30 June | 30 June | 31 Dec | |
|---|---|---|---|
| DKK 1,000 | 2015 | 2014 | 2014 |
| Biological assets carrying amount 01.01. | 1,013,959 | 965,895 | 965,895 |
| Increase due to production or purchases | 525,891 | 382,679 | 1,106,337 |
| Reduction due to harvesting or sale (costs of goods sold) | -538,942 | -413,192 | -1,029,122 |
| Fair value adjustment at the beginning of the period reversed | -284,855 | -296,402 | -296,402 |
| Fair value adjustments at the end of the period | 191,878 | 172,784 | 284,855 |
| Reversal of elimination at the beginning of the period | 51,342 | 33,738 | 33,738 |
| Eliminations | -56,749 | -32,720 | -51,342 |
| Biological assets carrying amount at the end of the period | 902,524 | 812,782 | 1,013,959 |
| Cost price biological assets | 752,525 | 656,846 | 764,675 |
| Capitalised interest | 14,870 | 15,872 | 15,771 |
| Fair value adjustments at the end of the period | 191,878 | 172,784 | 284,855 |
| Eliminations | -56,749 | -32,720 | -51,342 |
| Biological assets carrying amount | 902,524 | 812,782 | 1,013,959 |
| Biomass < 1 kg on average (tonnes live weight) | 3,003 | 2,159 | 1,834 |
| Biomass 1 kg < 4 kg on average (tonnes live weight) | 12,805 | 12,257 | 11,194 |
| Biomass > 4 kg on average (tonnes live weight) | 16,066 | 14,202 | 22,463 |
| Volume of biomass at sea (tonnes live weight) | 31,874 | 28,618 | 35,491 |
| Numbers of fish < 1 kg on average (thousand) | 5,549 | 5,439 | 5,055 |
| Numbers of fish 1 kg < 4 kg on average (thousand) | 5,077 | 5,988 | 4,948 |
| Numbers of fish > 4 kg on average (thousand) | 2,679 | 2,700 | 4,537 |
| Total numbers of fish (thousand) | 13,305 | 14,127 | 14,540 |
Intangible assets, that are purchased individually, are capitalised at acquisition cost. Intangible assets acquired in connection with the purchase of a business entity are capitalised at acquisition cost when the criteria for separate recognition are met.
Intangible assets with a limited economic lifespan are depreciated systematically. Intangible assets are written down to the recoverable amount if the expected financial benefits do not cover their carrying amount.
Costs relating to research and development are charged as expenses as they accrue. R&D costs are capitalised in the statement of financial position, when it can be demonstrated that the relevant R&D projects carry economic benefits, that they can be technically finalised, and that the company intends to and is financially able to reap the economic benefits.
Capitalised R&D costs are recognised at acquisition cost less accumulated depreciation and writedowns. Capitalised R&D costs are depreciated in a straight line over the asset's estimated period of use.
Sea farming licences, which are purchased either as part of an acquisition or business combination according to IFRS 3, are capitalised at cost less accumulated write-downs. Sea farming licences in the Faroe Islands are considered perpetual, given that certain preconditions regarding environmental protection and animal welfare are met. Consequently, sea farming licences are not depreciated systematically, but are subject to an annual impairment test. If the carrying amount exceeds the recoverable amount, licences are considered impaired, and write-downs are entered and charged to the Income Statement.
The assessment of indefinite life is reviewed annually to determine whether the indefinite life continues to be appropriate. If not, the change in useful life from indefinite to finite is made on a prospective basis.
Bakkafrost operates its sea farming activity in 13 identifiable CGUs based on single or groups of sea farming licenses.
Seven out of these licenses are issued by the government without consideration, and hence are not capitalised. These belong to the North region.
The other six CGUs are acquired as part of business combinations. Respectively, when acquiring the Vestlax Group and the Havsbrún Group, hence two groups of CGUs. These are belonging to the West region. Bakkafrost considers these as significant in comparison to Bakkafrost's total carrying amount of goodwill and intangible assets with indefinite useful lives. Bakkafrost has decided to disclose specific information concerning these two groups of CGUs.
The sea farming licenses in the Faroe Islands are defined as the right to utilise a given area of fjords for farming fish. There are no provisions as to the maximum allowed biomass at the given site, but the legislation has imposed strict measures to regulate the farming activity in order to be environmentally sustainable.
The sea farming licenses are issued with a nominal lifespan of 12 years. Licenses are renewed, unless there is a specific reason against renewal, based on failure to fulfil the veterinary conditions set by the authorities. In connection with renewal of licenses, authorities may only decline renewal if specific legislation on area planning, animal welfare or environmental protection is in conflict with renewal of the licenses. Special emphasis is to be placed on the fact, that it is renewals of existing licenses.
This actually means that sea farming licenses are operated in a 12-year rolling lifespan system, where the licenses are renewed every 12th year. In the very rare cases, where the authorities have declined to renew licenses in order the use locations for other purposes, the farmers have obtained licenses from the authorities at other locations.
Bakkafrost has therefore decided to account for sea farming licenses, which are capitalised, following the provisions for intangible rights with indefinite useful lives.
When the company assumes control over a separate business entity for a consideration that exceeds the fair value of the individual assets, the difference is entered as goodwill in the statement of financial position.
Goodwill deriving from purchases of subsidiaries and associates is presented under intangible assets.
Goodwill is not depreciated, but is tested for impairment annually or more often if there are indications that its value is lower than the carrying amount. When assessing the need to write-down goodwill, this is assigned to relevant cash flow generating units or groups, which are expected to benefit from the acquisition.
Write-downs are performed in accordance with an assessment of the recoverable value of each of the cash-flow generating units to which the goodwill is assigned. To identify the Group's cash-flow generating units, the assets are grouped according to the lowest level to which separate and independent cash flows may be ascribed. Recoverable value is calculated on the basis of value in use. This is arrived at by estimating future cash flows. Please refer to Note 9 for further description.
If the calculated value in use is less than the carrying amount of the cash-flow generating unit, goodwill is written down first, and then other assets as required.
| DKK 1,000 | Goodwill | Licences | TOTAL |
|---|---|---|---|
| Acquisition costs as at 01.01.15 | 4,537 | 290,138 | 294,675 |
| Acquisition costs as at 30.06.15 | 4,537 | 290,138 | 294,675 |
| Impairment 01.01.15 | 0 | 0 | 0 |
| Accumulated depreciation and write-downs as at 30.06.15 | 0 | 0 | 0 |
| Net book value as at 30.06.15 | 4,537 | 290,138 | 294,675 |
| Acquisition costs as at 01.01.14 | 4,537 | 290,138 | 294,675 |
| Acquisition costs as at 31.12.14 | 4,537 | 290,138 | 294,675 |
| Impairment 01.01.14 | 0 | 0 | 0 |
| Accumulated depreciation and write-downs as at 31.12.14 | 0 | 0 | 0 |
| Net book value as at 31.12.14 | 4,537 | 290,138 | 294,675 |
The Group tests intangible assets annually for impairment or more frequently if there are indications that the assets are impaired. The annual impairment test is performed at year-end. Bakkafrost has substantial assets with indefinite lives in the form of licenses. The licenses are subject to impairment testing in combination with goodwill in the annual test. Bakkafrost identifies each farming zone, which may contain one or a number of licences or farming sites as one cash-generating unit.
Impairment testing is carried out by calculating the net present value of estimated future cash flows (value in use) for the cash-generating unit, in line with IAS 36, and comparing the net present value of the cash flow towards the carrying amount of net assets held by the cash-generating unit (CGU). The cash flow used in the calculations represents the management's best estimate at the time of reporting. If the carrying amount is higher than the calculated value in use, the assets are considered impaired. The estimated cash flow is based on the assumption of continued operation. The basis for the estimated cash flow is the strategic plan for the following years. The strategic plans have been reviewed and the targets approved by the Group management.
All CGUs have the same operating assumptions since the operating conditions are predominantly the same all over the Faroe Islands. The considered operating conditions are costs of feed, smolt, harvest, packaging, transport and other costs. Other operating conditions considered the same are mortality, production time, fallowing and harvest weight. CAPEX is also assumed to be the same for all CGUs over the calculated period. All CGUs are calculated with the same WACC. If there will be variances between the assumptions for the different CGUs in the future, this will be incorporated into the impairment test.
The impairment testing at year-end did not result in identification of impairment losses. Intangible assets were tested for impairment to evaluate if the cash
flow from a conservative estimate was sufficient to support the carrying amount of net assets. The test confirmed the asset values.
The key assumptions in the calculations of value in use are harvest volume, prices and costs, hence EBIDTA and WACC. Amongst other assumptions are inflation, CAPEX and terminal growth.
In general, the value in use has been determined based on future strategic plans considering the expected development in both macroeconomic and company-related conditions.
The assumptions used rest on uncertainty with regard to product prices, input prices, biological performance and future regulatory frameworks. Costs can normally be estimated with a higher degree of accuracy than income. As profitability in the salmon farming industry historically has been very volatile, depending on developments in the prices of salmon. Bakkafrost uses budgets and long-term plans for the first five years of the analysis, but returns to longterm historic averages for profitability in the sixth year and terminal period.
The key assumptions used in determining the value in use are:
lation of the WACC, third-party sources are used where available (interest, inflation, beta). The discount rate is based on a five-year average for ten-year bonds issued by the Danish government, with an adjustment margin for the food industry in the EU.
In connection with the impairment testing of intangible assets, a sensitivity analysis has been carried out. Sensitivity analysis has been performed for each of the defined cash generating units. With the assumptions used, the headroom is DKK 511 million.
The CGUs tested are in the West region.
| CGUs (1,000) | Licenses | Other assets*** |
Total booked value tested |
WACC | Number of smolts |
EBITDA change of +/-1% |
WACC change of -1% |
WACC change of + 1% |
|---|---|---|---|---|---|---|---|---|
| Vestlax acquisition* | 132,706 | 526,116 | 658,822 | 10.8% | 6,400 | 65,564 | 181,995 | -102,513 |
| Havsbrún acquisition** | 157,430 | 231,021 | 388,451 | 10,8% | 2,800 | 28,685 | 55,106 | -72,189 |
| TOTAL | 290,136 | 757,137 | 1,047,273 | 10.8% | 9,200 | 94,249 | 237,101 | -174,702 |
| CGUs (1,000) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Vestlax acquisition* | 132,706 | 519,379 | 652,085 | 9.8% | 6,300 | 71,368 | 249,576 | -181,175 |
| Havsbrún acquisition** | 157,430 | 176,818 | 334,248 | 9.8% | 2,100 | 23,790 | 83,207 | -60,406 |
| TOTAL | 290,136 | 696,197 | 986,333 | 9.8% | 8,400 | 95,158 | 332,783 | -241,581 |
* 4 CGUs in license numbers A03, A05, A06, A25, A80 and A81. Acquired in 2010.
** 2 CGUs in license numbers A71 and A82. Acquired in 2011.
*** Other assets consist of goodwill, PP&E, inventory, receivables, etc. that can be allocated to CGUs or are directly attributable to CGUs.
| Farming segment | Q2 | Q2 | YTD | YTD |
|---|---|---|---|---|
| DKK 1,000 | 2015 | 2014 | 2015 | 2014 |
| External revenue | 484,361 | 310,274 | 825,551 | 624,229 |
| Internal revenue | 124,632 | 205,304 | 254,740 | 409,461 |
| Total revenue | 608,993 | 515,578 | 1,080,291 | 1,033,690 |
| Operating expenses | -343,476 | -340,986 | -602,678 | -658,383 |
| Depreciation and amortisation | -17,115 | -15,068 | -34,227 | -29,599 |
| Operational EBIT | 248,402 | 159,524 | 443,386 | 345,708 |
| Fair value adjustments on biological assets | -38,042 | -9,838 | -92,978 | -123,618 |
| Income from associates | -147 | 5,974 | -4,856 | -5,242 |
| Earnings before interest and taxes (EBIT) | 210,213 | 155,660 | 345,552 | 216,848 |
| Net interest revenue | -1,070 | 21 | -1,868 | 410 |
| Net interest expenses | 914 | -1,032 | -511 | -2,876 |
| Net currency effects | -7,240 | 10,242 | -12,214 | 1,715 |
| Other financial expenses | -2,980 | -1,524 | -4,442 | -2,551 |
| Earnings before taxes (EBT) | 199,837 | 163,367 | 326,517 | 213,546 |
| Taxes | -35,426 | -73,643 | -55,355 | -90,948 |
| Profit or loss for the period | 164,411 | 89,724 | 271,162 | 122,598 |
| VAP segment (Value added products) | Q2 | Q2 | YTD | YTD |
|---|---|---|---|---|
| DKK 1,000 | 2015 | 2014 | 2015 | 2014 |
| External revenue | 190,752 | 266,951 | 379,847 | 499,203 |
| Internal purchase of raw material | -124,632 | -205,304 | -254,740 | -409,461 |
| Operating expenses | -32,776 | -39,238 | -68,097 | -74,876 |
| Depreciation and amortisation | -1,853 | -1,948 | -3,655 | -3,868 |
| Operational EBIT | 31,491 | 20,461 | 53,355 | 10,998 |
| Provision for onerous contracts | 0 | 21 | 0 | 70,908 |
| Earnings before interest and taxes (EBIT) | 31,491 | 20,482 | 53,355 | 81,906 |
| Net interest revenue | 1,432 | 247 | 3,007 | 248 |
| Net interest expenses | 0 | -3 | -2 | -878 |
| Net currency effects | 0 | 0 | -3 | 0 |
| Other financial expenses | -4 | -5 | -8 | -13 |
| Earnings before taxes (EBT) | 32,919 | 20,721 | 56,349 | 81,263 |
| Taxes | -5,926 | -3,730 | -10,143 | -14,628 |
| Profit or loss for the period | 26,993 | 16,991 | 46,206 | 66,635 |
Condensed Consolidated Interim Report for Q2 2015 and H1 2015 Issued August 25th 2015
| FOF segment (Fishmeal, Fish Oil and Fish Feed) | Q2 | Q2 | YTD | YTD |
|---|---|---|---|---|
| DKK 1,000 | 2015 | 2014 | 2015 | 2014 |
| External revenue | 124,834 | 133,377 | 207,746 | 218,481 |
| Internal revenue | 158,687 | 146,740 | 280,703 | 239,688 |
| Total revenue | 283,521 | 280,117 | 488,449 | 458,169 |
| Purchase of goods | -181,231 | -163,643 | -281,499 | -283,476 |
| Operating expenses | -49,286 | -59,523 | -91,382 | -95,578 |
| Depreciation and amortisation | -7,357 | -6,335 | -14,695 | -12,458 |
| Operational EBIT | 45,647 | 50,616 | 100,873 | 66,657 |
| Income from associates | -10,649 | 4,101 | -8,807 | 8,220 |
| Earnings before interest and taxes (EBIT) | 34,998 | 54,717 | 92,066 | 74,877 |
| Net interest revenue | 117 | 422 | 274 | 631 |
| Net interest expenses | -7,101 | -6,936 | -13,413 | -12,754 |
| Net currency effects | -1,390 | -1,817 | 1,016 | -1,741 |
| Other financial expenses | -56 | -68 | -126 | -156 |
| Earnings before taxes (EBT) | 26,568 | 46,318 | 79,817 | 60,857 |
| Taxes | -4,782 | -8,337 | -14,367 | -10,954 |
| Profit or loss for the period | 21,786 | 37,981 | 65,450 | 49,903 |
| Reconciliation of reportable segments to Group | ||||||||
|---|---|---|---|---|---|---|---|---|
| earnings before taxes (EBT) | Q2 | Q2 | YTD | YTD | ||||
| DKK 1,000 | 2015 | 2014 | 2015 | 2014 | ||||
| Farming | 199,837 | 163,367 | 326,517 | 213,546 | ||||
| VAP (Value added products) | 32,919 | 20,721 | 56,349 | 81,263 | ||||
| FOF (Fishmeal, Fish Oil and Fish Feed) | 26,568 | 46,318 | 79,817 | 60,857 | ||||
| Eliminations | -22,121 | -18,487 | -79,958 | -25,747 | ||||
| Group earnings before taxes (EBT) | 237,203 | 211,919 | 382,725 | 329,919 |
| Assets and liablities per segment | 30 June | 30 June | 31 Dec |
|---|---|---|---|
| DKK 1,000 | 2015 | 2014 | 2014 |
| Farming | 3,438,096 | 3,163,710 | 3,305,566 |
| VAP (Value added products) | 239,900 | 113,131 | 187,328 |
| FOF (Fishmeal, Fish Oil and Fish Feed) | 821,556 | 849,434 | 754,904 |
| Eliminations | -1,001,852 | -985,996 | -784,865 |
| Total assets | 3,497,700 | 3,140,279 | 3,462,933 |
| Farming | -988,033 | -981,867 | -753,064 |
| VAP (Value added products) | -17,504 | -9,460 | -7,949 |
| FOF (Fishmeal, Fish Oil and Fish Feed) | -650,761 | -695,004 | -545,308 |
| Eliminations | 279,861 | 208,789 | -92,959 |
| Total liabilities | -1,376,437 | -1,477,542 | -1,399,280 |
| Distribution of harvested | Q2 | Q2 | YTD | YTD |
|---|---|---|---|---|
| volumes (tgw) | 2015 | 2014 | 2015 | 2014 |
| Harvested volume used in VAP production | 4,249 | 5,895 | 8,681 | 10,947 |
| Harvested volume sold fresh/frozen | 9,933 | 5,317 | 15,227 | 9,534 |
| Harvested and purchased volume (tgw) | 14,182 | 11,212 | 23,908 | 20,481 |
| Q2 | Q2 | YTD | YTD | |
|---|---|---|---|---|
| Harvested volumes (tgw) | 2015 | 2014 | 2015 | 2014 |
| Farming North | 11,681 | 7,874 | 18,866 | 8,195 |
| Farming West | 2,501 | 3,338 | 5,042 | 12,286 |
| Total harvested volumes (tgw) | 14,182 | 11,212 | 23,908 | 20,481 |
| Distribution of harvested | Q2 | Q2 | YTD | YTD |
|---|---|---|---|---|
| volumes (tgw) | 2015 | 2014 | 2015 | 2014 |
| Harvested volume used in VAP production | 30% | 53% | 36% | 53% |
| Harvested volume sold fresh/frozen | 70% | 47% | 64% | 47% |
| Harvested and purchased volumes (tgw) | 100% | 100% | 100% | 100% |
| Sales FOF | Q2 | Q2 | YTD | YTD |
|---|---|---|---|---|
| volumes (tonnes) | 2015 | 2014 | 2015 | 2014 |
| Feed internal | 15,551 | 14,784 | 27,961 | 25,382 |
| Feed external | 2,106 | 4,043 | 4,096 | 7,401 |
| Feed total | 17,657 | 18,827 | 32,057 | 32,783 |
| Fishmeal external | 9,900 | 11,046 | 15,251 | 14,683 |
| Fish oil external | 4 | 15 | 5 | 3,330 |
Condensed Consolidated Interim Report for Q2 2015 and H1 2015 Issued August 25th 2015
The Group had capital expenditure committed but not provided in these accounts at the date of the Statement of Financial Position of approximately DKK 520 million. DKK 116 million relate to the
Note 27 in Bakkafrost's Annual Report for 2014 provides detailed information on related parties' transactions.
Faroe Farming, an associated company of Bakkafrost, purchased for DKK 17.8 million from Bakkafrost in Q2 2015 and DKK 28.3 million in H1 2015. Bakkafrost purchased raw material amounting to DKK 20.0 million from Faroe Farming in Q2 2015 building of the new wellboat. DKK 242 million relate to the building of the new harvest and VAP factory, and DKK 121 million relate to the building of the new hatchery station.
and DKK 91.8 million in H1 2015. At the end of Q2 2015, Faroe Farming owed DKK 40.0 million to the Bakkafrost Group.
Transactions between P/F Bakkafrost and its subsidiaries meet the definition of related party transactions. As these transactions are eliminated on consolidation, they are not disclosed as related party transactions.
All assets/liabilities, for which fair value is recognised or disclosed, are categorised within the fair value hierarchy, described as follows, based on the lowest level input that is significant to the fair value measurement as a whole:
Level 1: Quoted market prices in an active market (that are unadjusted) for identical assets or liabilities.
Level 2: Valuation techniques (for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable).
Level 3: Valuation techniques (for which the lowest level input that is significant to the fair value measurement is unobservable).
For biological assets, the fair value calculation is done using a valuation model (level 3 in the valuation hierarchy) where the value is estimated based on observable market prices per period end.
For more information on these calculations, please refer to Note 2.13 and Note 14 in the Annual Report 2014.
For assets/liabilities that are recognised at fair value on a recurring basis, the Group determines, whether transfers have occurred between Levels in the hierarchy by reassessing categorisation (based on the lowest level input that is significant to the fair value measurement).
There have been no transfers into or out of Level 3 fair value measurements.
As at 30 June 2015, the Group held the following classes of assets/liabilities measured at fair value:
| DKK 1,000 | Carrying | ||||
|---|---|---|---|---|---|
| Assets and liabilities measured at fair value | Fair value | amount | Level 1 | Level 2 | Level 3 |
| Financial assets | 197 | 500 | 197 | 0 | 0 |
| Biological assets (biomass) | 902,525 | 752,525 | 0 | 0 | 902,525 |
| Assets measured at fair value 30/6- 2015 | 902,722 | 753,025 | 197 | 0 | 902,525 |
| Liabilities measured at fair value 30/6-2015 | 0 | 0 | 0 | 0 | 0 |
| Financial assets | 233 | 500 | 233 | 0 | 0 |
| Biological assets (biomass) | 1,013,959 | 729,104 | 0 | 0 | 1,013,959 |
| Assets measured at fair value 31/12- 2014 | 1,014,192 | 729,604 | 233 | 0 | 1,013,959 |
| Liabilities measured at fair value 31/12-2014 | 0 | 0 | 0 | 0 | 0 |
P/F Bakkafrost Bakkavegur 9 FO-625 Glyvrar Faroe Islands Telephone: +298 40 50 00 Fax: +298 40 50 09 Email: [email protected] Website: www.bakkafrost.com
Condensed Consolidated Interim Report for Q2 2015 and H1 2015 Issued August 25th 2015
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.